The report profiles some of the key players in the global dermal fillers market. These include
BioPlus Co., Ltd., Galderma laboratories, Bioxis pharmaceuticals, Suneva Medical, DR.
Korman, Sinclair Pharma, ALLERGAN, Merz Pharma, and CANDELA CORPORATION. Among
these, ALLERGAN was leading the global market in 2018 encompassing a large number of
specialized and technologically-advanced products. The company offers a JUVÉDERM
collection of dermal fillers, which includes lip enhancement and wrinkles correction.
Moreover, the company launched Juvéderm VOLUX to reduce fines lines on jawline and chin.
Another company called Merz Pharma recently launched a dermal filler product called
Belotero Revive to meet the unique skin requirements of aesthetic patients. Such product
launches are expected to help companies broaden their product portfolio, which will
stimulate growth in the market.
Browse Complete Report:
https://www.fortunebusinessinsights.com/industry-reports/dermal-fillers-market-100939
About us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping
organizations of all sizes make timely decisions. We tailor innovative solutions for our clients,
assisting them to address challenges distinct to their businesses. Our goal is to empower our
clients with holistic market intelligence, giving a granular overview of the market they are
operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help
companies achieve sustainable growth. Our team of experienced analysts and consultants use
industry-leading research tools and techniques to compile comprehensive market studies,
interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities
for our clients. We, therefore, offer recommendations, making it easier for them to navigate
through technological and market-related changes. Our consulting services are designed to
help organizations identify hidden opportunities and understand prevailing competitive
challenges.